sublayer

Working with the NHS


Rutherford Health plc is committed to establishing genuine partnerships with the NHS by providing necessary treatment and diagnostic capacity, using the most advanced equipment available across our network of centres and services, and supporting NHS objectives in delivering high-quality healthcare and outcomes to local communities. 

Rutherford Health currently has the following contracts in place:

Welsh Health Specialised Services Committee: Proton Beam Therapy for Adult Patients

In 2019, NHS Wales commissioned the Rutherford Cancer Centre South Wales to provide proton beam therapy to Welsh adult NHS patients. This is for an initial two years duration, after which its scope could expand to include more patients of different ages and with an increasing number of tumour types.

Proton beam therapy is currently available across the UK from three Rutherford Cancer Centres (Newport, Bedlington, and Reading). This means that there are more services available to NHS patients, where the Rutherford Cancer Centre is contracted to provide those services. Proton beam therapy is also available at The Christie NHS Foundation Trust in Manchester. 

NHS Shared Business Services: Outsourced Clinical Services Framework (OCSF)

The OCSF enables NHS organisations to commission services from the Rutherford Cancer Centres directly, offering an easy solution that avoids lengthy and costly tendering processes, where the Rutherford Cancer Centre is the most appropriate provider of specialist cancer services. It is effective from April 2020 and has an initial duration of two years, and could be extended for a further two years for the NHS to commission services in England and Wales. It is free of charge to use by the NHS. In addition to proton beam therapy, treatments available at the Rutherford Cancer Centres include:

  • Radiotherapy
  • Chemotherapy
  • Immunotherapy
  • CT (computerised tomography)
  • MRI (magnetic resonance imaging)
  • MR-linac (due to open late 2020 in Liverpool)

NHS Supply Chain: Mobile and Strategic Clinical Solutions And Associated Goods Framework

Rutherford Diagnostics is an approved provider in the Mobile and Strategic Clinical Solutions and Associated Goods Framework, managed by NHS Supply Chain. The Framework allows NHS Trusts to directly enter into a contract for Rutherford Diagnostic services, without the need for a lengthy and costly separate OJEU tender process. Under this Framework, Rutherford Diagnostics can provide the following clinical imaging services:

  • MRI
  • CT
  • PET-CT
  • Ultrasound
  • X-Ray